Kelsey-Leigh A Garcia

Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia.

E. Estey, C. Turtle, P. Nghiem, 2020, Blood advances.

Physician and patient perceptions on randomization of treatment intensity for unfit adults with acute myeloid leukemia and other high-grade myeloid neoplasm

E. Estey, M. Othus, R. Walter, 2022, Leukemia.

Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia

E. Estey, R. Walter, P. Becker, 2021, Cancer.

Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia

E. Estey, J. Radich, R. Walter, 2023, Leukemia & lymphoma.

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Initial Results of a Phase II Trial

E. Estey, J. Radich, P. Becker, 2018, Blood.

Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML

E. Estey, J. Abkowitz, M. Othus, 2023, Blood Advances.